Han Ju Yi

Title: Han Ju Yi: Innovating the Treatment of Visceralgia and Trigeminal Neuralgia

Introduction:

In the world of medical advancements, Han Ju Yi, hailing from Daejeon, South Korea, has made significant contributions through his patents and inventions. With a total of 9 patents to his name, Han Ju Yi stands out as a visionary inventor in the field of healthcare. His latest patents focus on the use of carbamate compounds to prevent, alleviate, or treat visceralgia, as well as preventing or treating trigeminal neuralgia. Currently working at SK Biopharmaceuticals Co., Ltd., Yi is surrounded by fellow innovators such as Eun Hee Chae and Sang Mi Chae, who contribute to the company's growth and innovation.

Patent 1: Use of a carbamate compound to prevent, alleviate or treat visceralgia or pain arising from visceral disease.

This patent explores the application of a carbamate compound, specifically the chemical formula 1, and its pharmaceutically permissible salt, solvate, or hydrate derivatives for the prevention, alleviation, or treatment of visceralgia. Visceralgia pertains to pain originating from visceral disease. Yi's invention presents a promising avenue for addressing the discomfort and suffering associated with such conditions.

Patent 2: Use of carbamate compound for preventing or treating trigeminal neuralgia.

Yi's second patent focuses on the development of a pharmaceutical composition for the prevention or treatment of trigeminal neuralgia. This composition consists of a carbamate compound, the chemical formula 1, or its pharmaceutically acceptable salt, solvate, or hydrate derivatives, along with a suitable carrier. By employing this composition, Yi aims to provide an efficient and effective solution for curing or managing trigeminal neuralgia.

Company: SK Biopharmaceuticals Co., Ltd.

Han Ju Yi is an esteemed member of SK Biopharmaceuticals Co., Ltd., a leading biopharmaceutical company known for its commitment to innovation and groundbreaking research. Located in Daejeon, South Korea, SK Biopharmaceuticals plays a crucial role in developing and producing novel therapies to tackle various health challenges.

Collaborators: Eun Hee Chae and Sang Mi Chae

Within SK Biopharmaceuticals, Han Ju Yi collaborates with talented individuals like Eun Hee Chae and Sang Mi Chae. Together, they strive to push the boundaries of medical science, finding new solutions and treatments to improve the lives of patients worldwide.

Conclusion:

Han Ju Yi's prowess in the field of healthcare innovation and patents showcases his dedication to improving the lives of individuals suffering from visceralgia and trigeminal neuralgia. Through his diligent work at SK Biopharmaceuticals Co., Ltd., Yi is part of a dynamic team working towards groundbreaking advances in the field. His patents demonstrate the potential for significant advancements in treating both visceralgia and trigeminal neuralgia, offering hope to those affected by these conditions.